Drugmaker Gilead will be administering the experimental drug Remdesivir to pediatric patients who contracted COVID-19.
The goal is to measure the effectiveness of the drug in newborns and adolescents.
Drugmaker Gilead will be administering the experimental drug Remdesivir to pediatric patients who contracted COVID-19.
The goal is to measure the effectiveness of the drug in newborns and adolescents.
Delhi reported 3,788 new coronavirus cases over the past 24 hours, government data showed Wednesday evening, taking the total..